
Keywords: Curcumin; Neuropathic pain (NP); Inflammatory pain; Depression; Bioavailability; ACE; angiotensin converting enzyme; AP-1; activator protein-1; AKT; protein kinase B; BDMC; bisdemethoxycurcumin; BDNF; brain-derived neurotrophic factor; CAT; catalase; CS;